8-K: Green Thumb Industries Reports Record Revenue and Adjusted EBITDA in Q4 2023, Expands Share Repurchase Program

Green Thumb Industries announced strong fourth quarter and full year 2023 results, including record revenue and adjusted EBITDA, and an increased share repurchase program.

Summary

• Green Thumb Industries reported a 7% year-over-year increase in fourth-quarter revenue, reaching $278 million.
• The company's full-year revenue for 2023 was $1.1 billion, a 4% increase compared to the previous year.
• Fourth-quarter GAAP net income was $3 million, or $0.01 per share, while full-year net income reached $36 million, or $0.15 per share.
• Adjusted EBITDA for the fourth quarter was $91 million, representing 33% of revenue, and full-year adjusted EBITDA was $326 million, or 31% of revenue.
• The company generated $71 million in cash flow from operations in the fourth quarter and $225 million for the full year.
• Green Thumb opened seven new RISE dispensaries in the fourth quarter, six in Florida and one in New York, bringing the total to 91 dispensaries across 14 states.
• The company repurchased $25 million of senior debt and $15 million of its shares in the fourth quarter.
• The board of directors authorized an additional $50 million for the share repurchase program, bringing the total remaining repurchase ability to approximately $60 million.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to record financial results, increased cash flow, and an expanded share repurchase program. The company's management is optimistic about future growth, and the financial metrics are generally strong. However, there are some risks and challenges mentioned, which prevent a perfect score.

Positives

• The company achieved record revenue and adjusted EBITDA in the fourth quarter of 2023.
• Green Thumb experienced a significant increase in cash flow from operations for the full year 2023.
• The company's gross profit margin improved in the fourth quarter, driven by revenue growth.
• Green Thumb expanded its retail presence by opening seven new dispensaries in the fourth quarter.
• The company is actively returning capital to shareholders through share repurchases and debt repurchases.
• The company has a strong balance sheet with $162 million in cash at the end of the year.
• The company completed a major capex program, positioning it for future growth.

Negatives

• Total selling, general, and administrative expenses increased as a percentage of revenue for both the fourth quarter and full year 2023.
• The company's comparable sales growth was relatively modest at 1.3% for the fourth quarter.

Risks

• Cannabis remains illegal under U.S. federal law, which could lead to changes in enforcement.
• State regulation of cannabis is uncertain and could impact the company's operations.
• The company may face difficulties in obtaining or maintaining necessary permits and authorizations.
• Green Thumb faces intense competition from both legal and illicit markets.
• The company is subject to unfavorable tax treatment as a cannabis business.
• The company's capital structure and voting control may cause unpredictability.
• Sales of substantial amounts of shares by shareholders may have an adverse effect on the market price.

Future Outlook

Management is optimistic about 2024 and beyond, citing industry-leading brands, a strong team, a loyal customer base, and financial flexibility to continue growth. The company plans to carry strong momentum into 2024.

Management Comments

• Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler stated that the team delivered a strong fourth quarter, including record revenue and adjusted EBITDA, while investing over $200 million in capex to fuel future growth.
• Ben Kovler also mentioned that the company completed its major capex program and authorized the first share repurchase program to return capital to shareholders.
• Green Thumb President Anthony Georgiadis highlighted the opening of fifteen new stores in 2023 and the expansion of cultivation and production facilities.

Industry Context

The results reflect the ongoing growth in the cannabis industry, particularly in states that have legalized adult-use cannabis, such as Maryland. The company's expansion and focus on branded products align with industry trends.

Comparison to Industry Standards

• Green Thumb's revenue growth of 4% for the full year is moderate compared to some other cannabis companies in the growth phase, but its focus on profitability and cash flow is a differentiator.
• The adjusted EBITDA margin of 31% for the full year is strong compared to many peers in the cannabis industry, indicating efficient operations.
• Companies like Curaleaf and Trulieve, which are also multi-state operators, have reported varying growth rates and profitability, making Green Thumb's performance competitive.
• The share repurchase program is a positive sign for investors, as it indicates management's confidence in the company's future prospects and a commitment to returning capital to shareholders, which is not always common in the cannabis sector.

Stakeholder Impact

• Shareholders will benefit from the increased share repurchase program and the company's improved financial performance.
• Employees will benefit from the company's growth and expansion.
• Customers will have access to more dispensaries and product offerings.
• The company's financial health will benefit creditors.

Next Steps

• The company will continue to execute its share repurchase program.
• Green Thumb will focus on expanding its retail footprint and product offerings.
• The company will continue to invest in its operations and infrastructure to support future growth.

Key Dates

Keywords

cannabis, Green Thumb Industries, financial results, revenue, EBITDA, dispensaries, share repurchase, retail, consumer packaged goods, debt repurchase